PodLumePodLumeSign in
R

retatrutide

Product

by Eli Lilly and Company

An investigational once-weekly medication that activates GLP-1, GIP, and glucagon receptors and is being studied for obesity, diabetes, and related metabolic conditions.

Learn more

1 episode featuring retatrutide

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

retatrutide | PodLume